BCDA
USDBioCardia Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.410
High
$1.410
Low
$1.320
Volume
0.07M
Company Fundamentals
Market Cap
14.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.60M
Exchange
NCM
Currency
USD
52-Week Range
Related News
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia with a Buy and maintains $25 price target.
BioCardia Announces Pricing of Up To $12 Million Public Offering
SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA) ("BioCardia" or the "Company"), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary Follow-up
SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the
BioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025
SUNNYVALE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- - BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today
Related Stocks
ONFOW
Onfolio Holdings Inc. Warrant
DLY
DoubleLine Yield Opportunities Fund Common Shares of Beneficial Interest
KVACW
Keen Vision Acquisition Corporation Warrant
NKGN
NKGen Biotech Inc.
BAYA
Bayview Acquisition Corp Ordinary Shares
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.